Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced today a key addition to the management team at its Singapore location. Saravanakumar Dhakshinamoorthy, Ph.D. joins AMRI’s Singapore site as Director of ...
read more
AMRI (NASDAQ: AMRI) announced today that its subsidiary, India Pvt. Ltd. has been recognized by Abbott Health Care Pvt. Ltd. for the reliable supply of generic medications for the period from April 2011 to March 2012. This is the second year in a row...
read more
Friday, November 30, 2012
AMRI announced today that as a next step in its SMARTSOURCING™ strategy it has taken further actions to expand and better integrate its in vitro biology services with its total drug discovery service platform.
read more
Monday, February 11, 2013
AMRI announced today that it has signed an exclusive license agreement with Chai Therapeutics, LLC for the development of ALB 109564(a), AMRI’s novel tubulin inhibitor compound in late Phase I testing for the treatment of cancer. This agreement ...
read more
Tuesday, December 18, 2012
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that Aptuit and Alios BioPharma, South San Francisco, California, are collaborating in lead optimization projects for two of Alios’ anti-viral targets.
read more
Tuesday, November 13, 2012
Aptuit LLC announced that the company has reached an agreement on a multiyear extension of its strategic partnership with GlaxoSmithKline (GSK) for dedicated drug development work at The Aptuit Center for Drug Discovery & Development in Verona, Italy...
read more
Monday, November 12, 2012
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced that the number of clients placing work at The Aptuit Center for Drug Discovery & Development in Verona, Italy has reached 100, giving the site a strong vote of confidence...
read more
Aptuit has announced that Dr. Maurizio Denaro has assumed responsibilities as General Manager of The Aptuit Center for Discovery & Development in Verona, Italy, effective July 15, 2013.
read more
Monday, February 11, 2013
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced the availability of GLP-qPCR Biodistribution Studies required as part of the preclinical development study package for application in First In Man (FIM) of Gene Therapy ...
read more
Thursday, October 18, 2012
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced the availability of bundled, comprehensive and integrated services in the antibacterial area from a single site, The Aptuit Center for Drug Discovery & Development in ...
read more
Wednesday, March 27, 2013
Aptuit announces that it offers fast screenings of synaptic activity on hippocampal slices for clients who are focused on the central nervous system (CNS) therapeutic area.
read more
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Thursday, January 08, 2015
Bob Hartwig, North American Representative for DIR Technologies – a provider of quality and process control solutions for pharmaceutical primary packaging – will deliver a presentation at Pack Expo East on the potential of disruptive technology and ...
read more
Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital
Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA. The
acquisition of MTL is the first step in the strategy of ATS to expand its microbiology...
read more
Wednesday, April 04, 2012
Somerset, NJ and Ludwigshafen, Germany – April 4, 2012 – Catalent Pharma Solutions and BASF have entered into a broad collaboration and Open Alliance to provide solutions to overcome bioavailability challenges of new molecular entities with ...
read more